Health Status Associated with SARS-CoV-2 Risk Perceptions in Sierra Leone and Zimbabwe
DOI:
https://doi.org/10.15566/cjgh.v11i1.815Keywords:
COVID-19, health status, risk factors, Zimbabwe, Sierra LeoneAbstract
Background & Aims. The COVID-19 pandemic had a significant impact on health in countries of every income level. While much is known about risk factors for COVID-19 severity, less is known about the relationship between COVID related risk perceptions and behaviors, particularly in low-income settings. The purpose of this study is to investigate the relationship between existing health status and COVID-19 risk perceptions and behaviors in Sierra Leone and Zimbabwe.
Methods. Data for this study came from a cross-sectional survey conducted simultaneously among 1158 adults in Sierra Leone and 1154 in Zimbabwe during July and August of 2022. Respondents were recruited from among communities served by the Christian Health Association of Sierra Leone (CHASL) and Zimbabwe Association of Church-Related Hospitals (ZACH), both members of the Africa Christian Health Associations Network (ACHAP).
Results. The relationship between health status and COVID-19 risk perceptions and behaviors varied significantly by health condition. Cardiovascular disease was significantly associated with heightened perceptions of COVID-19 risk, heightened perceived safety of COVID vaccines, and subsequent greater vaccine acceptance while cancer was likewise statistically significant in each of lower perceived susceptibility, perceived safety, and vaccination uptake. Similarly, obesity was associated with both lower perceived susceptibility of COVID-19 and decreased perceived safety of COVID vaccines.
Conclusion. Results suggest that the association between health conditions and COVID perceptions and behaviors is neither clear nor consistent across a variety of NCDs. Hence, findings from this study may inform public health interventions aimed at reducing COVID-19 morbidity and mortality, including increasing vaccine acceptance and uptake in Sierra Leone and Zimbabwe. Further, findings potentially have broader implications for understanding how health status is associated with COVID-19 risk perceptions in other LMICs.
References
Dong E, Du H, Gardner L. An interactive webbased
dashboard to track COVID-19 in real time.
Lancet Infect Dis. 2023;20(5):533-4. https://doi.
org/10.1016/S1473-3099(20)30120-1
World Health Organization, African Region
[Internet]. Geneva. Coronavirus (COVID-
. [Updated 2023 May; cited 2023 May 2].
Available from: https://www.afro.who.int/
health-topics/coronavirus-covid-19
Williamson EJ, Walker AJ, Bhaskaran K,
Bacon S, Bates C, Morton CE, et al. Factors
associated with COVID-19-related death using
OpenSAFELY. Nature. 2020;584(7821):430-6.
https://doi.org/10.1038/s41586-020-2521-4
Gowshall M, Taylor-Robinson S. The increasing
prevalence of non-communicable diseases in
low-middle income countries: the view from
Malawi. Int J Gen Med. 2018;11:255-64.
https://doi.org/10.2147/ijgm.s157987
Arokiasamy P, Uttamacharya, Kowal P,
Capistrant BD, Gildner TE, Thiele E, et al.
Chronic noncommunicable diseases in 6 lowand
middle-income countries: findings from
Wave 1 of the World Health Organization's Study
on Global Ageing and Adult Health (SAGE). Am
J Epidemiol. 2017;185(6):414-28. https://doi.
org/10.1093/aje/kww125
Ratzan SC, Sommariva S, Rauh L. Enhancing
global health communication during a crisis:
lessons from the COVID-19 pandemic. Public
Health Res Pract. 2020;30(2). https://doi.
org/10.17061/phrp3022010
Dessie ZG, Zewotir T. Mortality-related risk
factors of COVID-19: a systematic review
and meta-analysis of 42 studies and 423,117
patients. BMC Infect Dis. 2021;21(1):855.
Epub 20210821. https://doi.org/10.1186/
s12879-021-06536-3
Lazarus JV, Ratzan SC, Palayew A, Gostin LO,
Larson HJ, Rabin K, et al. A global survey of
potential acceptance of a COVID-19 vaccine.
Nature Med. 2021;27(2):225-8. https://doi.
org/10.1038/s41591-020-1124-9
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19
in Wuhan, China: a retrospective cohort study.
Lancet. 2020;395(10229):1054-62. https://doi.
org/10.1016/s0140-6736(20)30566-3
Bepouka B, Mayasi N, Mandina M, Longokolo
M, Odio O, Mangala D, et al. Risk factors for
mortality in COVID-19 patients in sub-Saharan
Africa: a systematic review and meta-analysis.
PLOS ONE. 2022;17(10):e0276008. https://doi.
org/10.1371/journal.pone.0276008
Popkin BM, Du S, Green WD, Beck MA,
Algaith T, Herbst CH, et al. Individuals with
obesity and COVID-19: a global perspective
on the epidemiology and biological relationships.
Obesity Rev. 2020;21(11). https://doi.
org/10.1111/obr.13128
Vallis M, Glazer S. Protecting individuals
living with overweight and obesity: attitudes
and concerns toward COVID-19 vaccination
in Canada. Obesity. 2021;29(7):1128-37. https://
doi.org/10.1002/oby.23182
lqudeimat Y, Alenezi D, AlHajri B, Alfouzan H,
Almokhaizeem Z, Altamimi S, et al. Acceptance
of a COVID-19 vaccine and its related
determinants among the general adult population
in Kuwait. Med Princ Prac. 2021;30(3):262-71.
https://doi.org/10.1159/000514636
Ho AS, Mitchell ES, Lee J, Steptoe A, Behr H,
May CN, et al. Predictive capacity of COVID-
-related risk beliefs on weight management
behaviors on a commercial weight loss
program and speed of COVID-19 vaccination
uptake: prospective cohort study. BMC Public
Health. 2022;22(1). https://doi.org/10.1186/
s12889-022-14481-2
Lee LYW, Cazier J-B, Starkey T, Briggs SEW,
Arnold R, Bisht V, et al. COVID-19 prevalence
and mortality in patients with cancer and the
effect of primary tumour subtype and patient
demographics: a prospective cohort study.
Lancet Oncol. 2020;21(10):1309-16. https://doi.
org/10.1016/s1470-2045(20)30442-3
Singh AK, Gillies CL, Singh R, Singh A,
Chudasama Y, Coles B, et al. Prevalence
of co-morbidities and their association
with mortality in patients with COVID-
: a systematic review and meta-analysis.
Diabetes Obesity Metab. 2020;22(10):1915-24.
https://doi.org/10.1111/dom.14124
Liang W, Guan W, Chen R, Wang W, Li J, Xu K,
et al. Cancer patients in SARS-CoV-2 infection:
a nationwide analysis in China. Lancet Oncol.
;21(3):335-7. https://doi.org/10.1016/
s1470-2045(20)30096-6
Lee LYW, Cazier J-B, Angelis V, Arnold R, Bisht
V, Campton NA, et al. COVID-19 mortality in
patients with cancer on chemotherapy or other
anticancer treatments: a prospective cohort study.
Lancet. 2020;395(10241):1919-26. https://doi.
org/10.1016/s0140-6736(20)31173-9
MacDonald NE. Vaccine hesitancy:
definition, scope and determinants. Vaccine.
;33(34):4161-4. https://doi.org/10.1016/j.
vaccine.2015.04.036
Tsai R, Hervey J, Hoffman K, Wood J, Johnson J,
Deighton D, et al. COVID-19 vaccine hesitancy
and acceptance among individuals with cancer,
autoimmune diseases, or other serious comorbid
conditions: cross-sectional, internet-based survey.
JMIR Public Health Surveill. 2022;8(1):e29872.
Noronha V, Abraham G, Bondili S, Rajpurohit
A, Menon R, Gattani S, et al. COVID-19 vaccine
uptake and vaccine hesitancy in Indian patients
with cancer: a questionnaire-based survey.
Cancer Res Stat Treat. 2021;4(2). https://doi.
org/10.4103/crst.crst_138_21
Mejri N, Berrazega Y, Ouertani E, Rachdi H,
Bohli M, Kochbati L, et al. Understanding
COVID-19 vaccine hesitancy and resistance:
another challenge in cancer patients. Support
Care Cancer. 2022;30(1):289-93. https://doi.
org/10.1007/s00520-021-06419-y
Becerra MB, Becerra BJ. COVID-19
vaccine hesitancy among behavioral risk
takers. Vaccines. 2022;10(5):767. https://doi.
org/10.3390/vaccines10050767
Rodriguez M, López-Cepero A, Ortiz-
Martínez AP, Fernández-Repollet E, Pérez
CM. Influence of health beliefs on COVID-19
vaccination among individuals with cancer and
other comorbidities in Puerto Rico. Vaccines.
;9(9):994. https://doi.org/10.3390/
vaccines9090994
Fang L, Karakiulakis G, Roth M. Are patients
with hypertension and diabetes mellitus at
increased risk for COVID-19 infection?
Lancet Respir Med. 2020;8(4):e21. https://doi.
org/10.1016/S2213-2600(20)30116-8
Alqahtani JS, Oyelade T, Aldhahir AM,
Alghamdi SM, Almehmadi M, Alqahtani
AS, et al. Prevalence, severity and mortality
associated with COPD and smoking in patients
with COVID-19: a rapid systematic review and
meta-analysis. PLoS One. 2020;15(5):e0233147.
https://doi.org/10.1371/journal.pone.0233147
Narain JP. COVID-19 and chronic
noncommunicable diseases: profiling a deadly
relationship. Int J Noncommun Dis. 2020;5(2):25-
https://doi.org/10.4103/jncd.jncd_36_20
World Health Organization, editor. The impact of
the COVID-19 pandemic on noncommunicable
disease resources and services: results of a rapid
assessment [Internet]. WHO; 2020. Available
from: https://www.who.int/publications/i/
item/9789240010291
Matsungo TM, Chopera P. Effect of the COVID-
-induced lockdown on nutrition, health and
lifestyle patterns among adults in Zimbabwe.
BMJ Nutri Prev Health. 2020;3(2):205-12.
https://doi.org/10.1136/bmjnph-2020-000124
Lakoh S, Jiba DF, Baldeh M, Adekanmbi O,
Barrie U, Seisay AL, et al. Impact of COVID-19
on Tuberculosis case detection and treatment
outcomes in Sierra Leone. Trop Med Infect
Dis. 2021;6(3). https://doi.org/10.3390/
tropicalmed6030154
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dennis Kinyoki, Ruth Gemi, Gertrude Guveya, James Mukabi, Jaya Shreedhar, Fifi Manuel, Alex Anderson, Cougar P Hall, Josh West, Benjamin Crookston
This work is licensed under a Creative Commons Attribution 4.0 International License.
Christian Journal for Global Health applies the Creative Commons Attribution License to all articles that we publish. Under this license, authors retain ownership of copyright for their articles or they can transfer copyright to their institution, but authors allow anyone without permission to copy, distribute, transmit, and/or adapt articles, even for commercial purposes so long as the original authors and Christian Journal for Global Health are appropriately cited.
This work is licensed under a Creative Commons Attribution 4.0 International License.
40.jpg){kind=logo}
.jpg)
1.jpg)
